BioMarin Pharmaceutical Inc. at Cantor Global Healthcare Conference Transcript
Okay. Hi, good morning, everyone. Welcome to day two of our Cantor Healthcare Conference. My name's Olivia Brayer. I'm one of the senior biotech analysts here at Cantor, and really excited about this morning's fireside chat with the BioMarin team. We have Cristin Hubbard, who is Chief Commercial Officer; and Greg Friberg, who is Chief R&D Officer. Thank you both so much for being here and making the trip to New York.
Thank you for having us.
Thank you.
It's been a really busy year for BioMarin. A lot has changed. You've done some deals. You've added some new assets. Maybe just talk about the state of the company today, how it's evolved over time, and what the vision
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
